Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform-Reference-Cited by-同舟云学术

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

Published:2017-10-30 Issue:1 Volume:14 Page:59-66
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

MacDonald Lisa D.¹^ORCID,MacKay Alecia¹,Kaliaperumal Valarmathy¹,Weir Genevieve¹^ORCID,Penwell Andrea¹^ORCID,Rajagopalan Rajkannan¹,Langley Joanne M.²³⁴^ORCID,Halperin Scott²³⁵,Mansour Marc¹,Stanford Marianne M.¹²⁵^ORCID

Affiliation:

1. Immunovaccine Inc., Halifax, Nova Scotia, Canada

2. Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia, Canada

3. Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada

4. Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada

5. Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1375637

Reference31 articles.

1. Accelerating Next-Generation Vaccine Development for Global Disease Prevention

2. Application of “Systems Vaccinology” to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines

3. Modern Subunit Vaccines: Development, Components, and Research Opportunities

4. Vaccine Adjuvants: from 1920 to 2015 and Beyond

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An explanation of the pathogenesis of several autoimmune diseases in immuno‐compromised individuals;Scandinavian Journal of Immunology;2020-11-16

2. Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein;Human Vaccines & Immunotherapeutics;2020-06-12

3. Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillus anthracis spore inhalation challenge;npj Vaccines;2019-02-08